511509 — Vivo Bio Tech Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹671.55m
- IN₹1.26bn
- IN₹522.30m
- 76
- 58
- 85
- 90
2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | C2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 18.2 | 42.5 | 86.2 | 44.7 | 46.2 |
Depreciation | |||||
Non-Cash Items | 4.23 | 1.88 | -29.4 | 39.9 | 76.5 |
Other Non-Cash Items | |||||
Changes in Working Capital | -80.8 | -10.1 | 29 | 7.3 | -142 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.76 | 86.1 | 142 | 166 | 73.7 |
Capital Expenditures | -35.3 | -102 | -228 | -511 | -40 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -35.3 | -102 | -228 | -511 | -40 |
Financing Cash Flow Items | — | — | — | -28.1 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 7.18 | 20.9 | 87.8 | 350 | -37.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -35.9 | 4.66 | 1.37 | 5.48 | -3.35 |